Frida Stock

4.1k total citations · 2 hit papers
47 papers, 3.0k citations indexed

About

Frida Stock is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Frida Stock has authored 47 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 22 papers in Epidemiology and 15 papers in Molecular Biology. Recurrent topics in Frida Stock's work include Antimicrobial Resistance in Staphylococcus (9 papers), Mycobacterium research and diagnosis (8 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Frida Stock is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (9 papers), Mycobacterium research and diagnosis (8 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Frida Stock collaborates with scholars based in United States, Brazil and Chile. Frida Stock's co-authors include Adrian M. Zelazny, Tara N. Palmore, David K. Henderson, Vee J. Gill, Evan S. Snitkin, Julia A. Segre, Pamela J. Thomas, Patrick R. Murray, V J Gill and Steven M. Holland and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Frida Stock

45 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing

2012 647 citations Evan S. Snitkin, Adrian M. Zelazny et al. Science Translational Medicine profile →
Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma

2002 565 citations John Toso, Vee J. Gill et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Frida Stock

Since Specialization

Citations

This map shows the geographic impact of Frida Stock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frida Stock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frida Stock more than expected).

Fields of papers citing papers by Frida Stock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frida Stock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frida Stock. The network helps show where Frida Stock may publish in the future.

Co-authorship network of co-authors of Frida Stock

This figure shows the co-authorship network connecting the top 25 collaborators of Frida Stock. A scholar is included among the top collaborators of Frida Stock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frida Stock. Frida Stock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical significance and antifungal susceptibility profile of 103 clinical isolates of Scedosporium species complex and Lomentospora prolificans obtained from NIH patients 2025 ·Journal of Clinical Microbiology ·(unknown), Jennifer Cuellar‐Rodríguez, (unknown), Frida Stock, (unknown), Kenneth N. Olivier, Kevin P. Fennelly, Juan Gea‐Banacloche, Christa S. Zerbe, Alexandra F. Freeman, Steven M. Holland, Michail S. Lionakis, Seyedmojtaba Seyedmousavi	3
2	2758. Clinical Significance and Antifungal Susceptibility Profile of 103 Clinical Scedosporium Species Complex and Lomentospora prolificans Isolated from NIH Hospitalized Patients 2023 ·Open Forum Infectious Diseases ·(unknown), Frida Stock, (unknown), Michail S. Lionakis, Jennifer Cuellar‐Rodríguez, (unknown)	0
3	Adaptability and Persistence of the Emerging Pathogen Bordetella petrii 2013 ·PLoS ONE ·Adrian M. Zelazny, Li Ding, Joanna B. Goldberg, Lilia A. Mijares, Sean Conlan, Patricia S. Conville, Frida Stock, Samuel Ballentine, Kenneth N. Olivier, Elizabeth P. Sampaio, Patrick R. Murray, Steven M. Holland	13
4	Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing breakdown → 2012 ·Science Translational Medicine ·Evan S. Snitkin, Adrian M. Zelazny, Pamela J. Thomas, Frida Stock, (unknown), David K. Henderson, Tara N. Palmore, Julia A. Segre	647
5	Identification of clinical isolates of anaerobic bacteria using matrix-assisted laser desorption ionization-time of flight mass spectrometry 2012 ·European Journal of Clinical Microbiology & Infectious Diseases ·Daniel P. Fedorko, Steven K. Drake, Frida Stock, Patrick R. Murray	70
6	RecurrentGranulibacter bethesdensisInfections and Chronic Granulomatous Disease 2010 ·Emerging infectious diseases ·David E. Greenberg, Adam R. Shoffner, Adrian M. Zelazny, (unknown), Kol A. Zarember, Frida Stock, Li Ding, Kimberly R. Marshall‐Batty, Richard L. Wasserman, David Welch, Kishore Kanakabandi, Dan E. Sturdevant, Kimmo Virtaneva, Stephen F. Porcella, Patrick R. Murray, Harry L. Malech, Steven M. Holland	30
7	A Cluster of Cases of Nosocomial Legionnaires Disease Linked to a Contaminated Hospital Decorative Water Fountain 2009 ·Infection Control and Hospital Epidemiology ·Tara N. Palmore, Frida Stock, (unknown), (unknown), (unknown), John E. Bennett, Patrick R. Murray, David K. Henderson	66
8	RecurrentBurkholderiaInfection in Patients with Chronic Granulomatous Disease: 11‐Year Experience at a Large Referral Center 2009 ·Clinical Infectious Diseases ·David E. Greenberg, Joanna B. Goldberg, Frida Stock, Patrick R. Murray, Steven M. Holland, John J. LiPuma	36
9	A Cluster of Hemodialysis-Related Bacteremia Linked to Artificial Fingernails 2007 ·Infection Control and Hospital Epidemiology ·Fred M. Gordin, Maureen E. Schultz, (unknown), (unknown), Frida Stock, (unknown)	15
10	A Novel Bacterium Associated with Lymphadenitis in a Patient with Chronic Granulomatous Disease 2006 ·PLoS Pathogens ·David E. Greenberg, Li Ding, Adrian M. Zelazny, Frida Stock, (unknown), Victoria Anderson, Georgina Miller, David E. Kleiner, Allan R. Tenorio, Lauren Brinster, David W. Dorward, Patrick R. Murray, Steven M. Holland	55
11	Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products 2004 ·Cytotherapy ·Hanh Khuu, Frida Stock, (unknown), (unknown), (unknown), (unknown), E.J. Read	26
12	Reinfection, Rather than Persistent Infection, in Patients with Chronic Granulomatous Disease 2003 ·The Journal of Infectious Diseases ·Shireen V. Guide, Frida Stock, Vee J. Gill, Victoria Anderson, Harry L. Malech, John I. Gallin, Steven M. Holland	38
13	Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma breakdown → 2002 ·Journal of Clinical Oncology ·John Toso, Vee J. Gill, Patrick Hwu, Francesco M. Marincola, Nicholas P. Restifo, Douglas J. Schwartzentruber, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Frida Stock, (unknown), Kathleen E. Morton, Claudia A. Seipp, Leah Haworth, Sharon Mavroukakis, Donald White, Susan MacDonald, John Mao, Mario Sznol, Steven A. Rosenberg	565
14	Development of a Rapid Real-Time PCR Assay for Quantitation ofPneumocystis cariniif. sp.carinii 2002 ·Journal of Clinical Microbiology ·Hans Henrik Larsen, Joseph A. Kovacs, Frida Stock, (unknown), Bettina Lundgren, Steven H. Fischer, Vee J. Gill	49
15	Detection ofLegionellaby PCR in Respiratory Specimens Using a Commercially Available Kit 1998 ·American Journal of Clinical Pathology ·Susan C. Weir, Steven H. Fischer, Frida Stock, Vee J. Gill	24
16	Lack of Clinical Utility of Bronchoalveolar Lavage Cultures for Cytomegalovirus in HIV Infection 1997 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), James H. Shelhamer, Henry Masur, V J Gill, William D. Travis, D. Solomon, Jody Manischewitz, Frida Stock, H. Clifford Lane, Frederick P. Ognibene	25
17	Infections WithRoseomonas gilardiiand Review of Characteristics Used for Biochemical Identification and Molecular Typing 1997 ·American Journal of Clinical Pathology ·(unknown), Frida Stock, Denise Williams, Susan C. Weir, Vee J. Gill	28
18	Successful Treatment of Stomatococcus mucilaginosus Meningitis with Intravenous Vancomycin and Intravenous Ceftriaxone 1997 ·Clinical Infectious Diseases ·(unknown), Jabbar Khan, Frida Stock, Daniel R. Lucey	7
19	Lysis—centrifugation blood cultures in the detection of tissue-proven invasive candidiasis disseminated versus single-organ infection 1993 ·Diagnostic Microbiology and Infectious Disease ·Juan Berenguer, (unknown), Frank G. Witebsky, Frida Stock, Philip A. Pizzo, Thomas J. Walsh	211
20	Diagnosis of Pneumocystis carinii Pneumonia by Multiple Lobe, Site-directed Bronchoalveolar Lavage with Immunofluorescent Monoclonal Antibody Staining in Human Immunodeficiency Virus-infected Patients Receiving Aerosolized Pentamidine Chemoprophylaxis 1992 ·American Review of Respiratory Disease ·Stewart J. Levine, Daniel Kennedy, James H. Shelhamer, Andrea Kovacs, Irwin M. Feuerstein, Vee J. Gill, Frida Stock, Diane Solomon, C. Thomas Boylen, Henry Masur, (unknown)	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact